Table 3.
Pharmacologically treated vs. not treated patients’ placentas and pO₂ levels.
| Features | Any therapy (n=34) | No therapy (n=23) | p-value |
|---|---|---|---|
| Gestational age at delivery (wks) | 38.9 ± 1.3 | 38.7 ± 1.1 | 0.454 |
| Placental Weight (g) | 506.1 ± 85.5 | 453.6 ± 69.5 | 0.032 |
| Fetal Placental/Weight ratio | 6.4 ± 0.9 | 6.7 ± 0.9 | 0.258 |
| Placental Diagnoses | |||
| Normal | 12 (35.3%) | 8 (34.8%) | 0.968 |
| Delayed Villous Maturation | 8 (23.5%) | 1 (4.3%) | 0.051 |
| Fetal Vascular Malperfusion (FVM) | 0 (0%) | 1 (4.3%) | 0.220 |
| Chorioamnionitis | 0 (0%) | 2 (8.7%) | 0.080 |
| Chronic Inflammation | 5 (14.7%) | 5 (21.7%) | 0.493 |
| Maternal Vascular Malperfusion (MVM) | 9 (26.5%) | 6 (26.1%) | 0.974 |
| Cord pO₂ (mmHg) | 33.24 ± 14.83 | 34.82 ± 15.98 | 0.810 |
Continuous variables are expressed as mean ± standard deviation (SD). All the other features are expressed as categorical variables in frequencies and their percentages in the brackets.